avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Atf5 | mm10_v2_chr7_-_44815658_44815682 | -0.11 | 5.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_-_41314700 Show fit | 2.57 |
ENSMUST00000064324.5
|
trypsin 5 |
|
chr14_+_54936456 Show fit | 0.90 |
ENSMUST00000037814.6
|
CKLF-like MARVEL transmembrane domain containing 5 |
|
chr3_-_18243289 Show fit | 0.65 |
ENSMUST00000035625.6
|
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
chr1_-_153851189 Show fit | 0.64 |
ENSMUST00000059607.6
|
RIKEN cDNA 5830403L16 gene |
|
chr4_+_21727695 Show fit | 0.63 |
ENSMUST00000065928.4
|
cyclin C |
|
chr10_+_115384951 Show fit | 0.60 |
ENSMUST00000036044.8
|
zinc finger, C3H1-type containing |
|
chrX_+_42150672 Show fit | 0.59 |
ENSMUST00000069619.7
|
stromal antigen 2 |
|
chr11_-_20112876 Show fit | 0.58 |
ENSMUST00000000137.7
|
ARP2 actin-related protein 2 |
|
chrX_+_42151002 Show fit | 0.57 |
ENSMUST00000123245.1
|
stromal antigen 2 |
|
chr15_+_12117848 Show fit | 0.57 |
ENSMUST00000128475.1
ENSMUST00000134277.1 |
zinc finger RNA binding protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.7 | GO:0007586 | digestion(GO:0007586) |
0.1 | 1.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 1.2 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 1.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.2 | 0.6 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 0.6 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.1 | 0.6 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.5 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.2 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.6 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.4 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.3 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.0 | 0.3 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 1.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.6 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.0 | 0.6 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 0.6 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.5 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.4 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 1.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 1.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |